2024 Q1 Form 10-K Financial Statement
#000121390024028732 Filed on April 01, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | $7.490M | $6.836M | $6.836M |
YoY Change | 187.78% | -49.9% | -49.9% |
Cost Of Revenue | $4.837M | $3.401M | $3.401M |
YoY Change | 360.19% | -37.15% | -37.15% |
Gross Profit | $2.653M | $3.435M | $3.435M |
YoY Change | 70.98% | -58.28% | -58.28% |
Gross Profit Margin | 35.42% | 50.25% | 50.25% |
Selling, General & Admin | $2.669M | $7.971M | $7.971M |
YoY Change | 13.89% | -44.64% | -44.64% |
% of Gross Profit | 100.6% | 232.06% | 232.06% |
Research & Development | $2.336M | $2.336M | |
YoY Change | -50.21% | -50.21% | |
% of Gross Profit | 67.99% | 67.99% | |
Depreciation & Amortization | $3.247M | $147.4K | $918.9K |
YoY Change | 926.55% | -91.53% | -88.27% |
% of Gross Profit | 122.39% | 4.29% | 26.75% |
Operating Expenses | $9.050M | $10.33M | $10.33M |
YoY Change | 160.01% | -58.18% | -83.77% |
Operating Profit | -$1.560M | -$6.899M | -$6.899M |
YoY Change | -19.13% | -58.13% | -87.56% |
Interest Expense | $326.0K | -$1.130M | -$1.130M |
YoY Change | -166.9% | -69.24% | 32.4% |
% of Operating Profit | |||
Other Income/Expense, Net | -$10.18M | -$573.3K | -$1.704M |
YoY Change | 1484.39% | 159.29% | -56.27% |
Pretax Income | -$11.74M | -$8.603M | -$8.603M |
YoY Change | 356.64% | -85.5% | -85.5% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$11.74M | -$11.58M | -$11.58M |
YoY Change | 374.58% | -85.53% | -85.35% |
Net Earnings / Revenue | -156.8% | -169.36% | -169.36% |
Basic Earnings Per Share | -$0.36 | -$31.21 | |
Diluted Earnings Per Share | -$0.40 | -$31.20 | -$31.21 |
COMMON SHARES | |||
Basic Shares Outstanding | 38.80M shares | 10.25M shares | 371.0K shares |
Diluted Shares Outstanding | 32.44M shares | 371.0K shares |
Balance Sheet
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.924M | $1.171M | $768.5K |
YoY Change | 118.23% | 33.46% | -12.45% |
Cash & Equivalents | $1.737M | $768.5K | |
Short-Term Investments | $187.0K | $403.0K | |
Other Short-Term Assets | $908.0K | $49.76K | |
YoY Change | -92.9% | -99.61% | |
Inventory | |||
Prepaid Expenses | $98.00K | $581.0K | |
Receivables | $290.0K | $147.9K | $147.9K |
Other Receivables | $370.3K | $370.3K | |
Total Short-Term Assets | $7.095M | $1.336M | $1.336M |
YoY Change | 161.66% | -91.03% | -91.03% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $10.17M | $21.69K | $21.69K |
YoY Change | 25039.08% | -55.63% | -55.63% |
Goodwill | |||
YoY Change | |||
Intangibles | $100.0K | $100.0K | |
YoY Change | -95.38% | ||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | $0.00 | |
YoY Change | |||
Total Long-Term Assets | $10.69M | $21.69K | $21.69K |
YoY Change | 149.42% | -99.53% | -99.53% |
TOTAL ASSETS | |||
Total Short-Term Assets | $7.095M | $1.336M | $1.336M |
Total Long-Term Assets | $10.69M | $21.69K | $21.69K |
Total Assets | $17.78M | $1.358M | $1.358M |
YoY Change | 154.17% | -93.02% | -93.02% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $5.120M | $2.165M | $2.165M |
YoY Change | 190.77% | 43.37% | 43.37% |
Accrued Expenses | $2.030M | $1.415M | $2.407M |
YoY Change | 67.73% | -28.02% | 22.45% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Long-Term Debt Due | $23.04M | $5.149M | $5.149M |
YoY Change | 234.64% | -60.99% | -60.99% |
Total Short-Term Liabilities | $30.19M | $10.37M | $10.37M |
YoY Change | 169.4% | -54.37% | -54.37% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | ||
YoY Change | -100.0% | ||
Other Long-Term Liabilities | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | -100.0% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $30.19M | $10.37M | $10.37M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $30.19M | $10.37M | $10.37M |
YoY Change | 136.18% | -57.32% | -57.32% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$58.18M | -$179.1M | |
YoY Change | -65.78% | 6.91% | |
Common Stock | $45.77M | $164.6M | |
YoY Change | -71.7% | 2.73% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$12.41M | -$9.011M | -$9.011M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $17.78M | $1.358M | $1.358M |
YoY Change | 154.17% | -93.02% | -93.02% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$11.74M | -$11.58M | -$11.58M |
YoY Change | 374.58% | -85.53% | -85.35% |
Depreciation, Depletion And Amortization | $3.247M | $147.4K | $918.9K |
YoY Change | 926.55% | -91.53% | -88.27% |
Cash From Operating Activities | -$983.0K | -$682.0K | -$5.888M |
YoY Change | -61.26% | 51.61% | -45.98% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $637.4K | $1.237M |
YoY Change | -100.0% | 12647.2% | 205.52% |
Cash From Investing Activities | $637.4K | $1.237M | |
YoY Change | -162.44% | -131.15% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $1.805M | 650.0K | -$2.767M |
YoY Change | -136.71% | 360.57% | -132.05% |
NET CHANGE | |||
Cash From Operating Activities | -$983.0K | -682.0K | -$5.888M |
Cash From Investing Activities | 637.4K | $1.237M | |
Cash From Financing Activities | $1.805M | 650.0K | -$2.767M |
Net Change In Cash | $822.0K | 605.4K | -$7.415M |
YoY Change | -112.09% | -145.54% | 18.46% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$983.0K | -$682.0K | -$5.888M |
Capital Expenditures | |||
Free Cash Flow | -$983.0K | ||
YoY Change | -61.26% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
371020 | shares |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-39096 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
GRYPHON DIGITAL MINING, INC. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
83-2242651 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5953 Mabel Road | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Unit 138 | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Las Vegas | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NV | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
89110 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
(877) | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
646-3374 | |
CY2023 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.0001 per share | |
CY2023 | dei |
Trading Symbol
TradingSymbol
|
GRYP | |
CY2023 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
4100000 | usd |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
38800340 | shares |
CY2023Q4 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023 | dei |
Auditor Name
AuditorName
|
Marcum llp | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Los Angeles, CA | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
768461 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
877844 | usd |
CY2022Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
7000000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
147855 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
429949 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
420082 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1121763 | usd |
CY2022Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
1328784 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1336398 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
10758340 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
21689 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
48880 | usd |
CY2022Q4 | us-gaap |
Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
|
8661272 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
1358087 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
19468492 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4820630 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4023183 | usd |
CY2022Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
2283806 | usd |
CY2023Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
399652 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
568771 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
5149000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
13200000 | usd |
CY2022Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
2432374 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10369282 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
22508134 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
161803 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1407000 | usd |
CY2022Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
|
217083 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
10369282 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
24294020 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
517605 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
517605 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
230140 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
230140 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
52 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
23 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
164583630 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
160207804 | usd |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
227000 | usd |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
347100 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-179144015 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-167565846 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9011195 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4825528 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1358087 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
19468492 | usd |
CY2023 | us-gaap |
Revenues
Revenues
|
6836444 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
10458170 | usd |
CY2023 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
3401441 | usd |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
4911503 | usd |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
3435003 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
5546667 | usd |
CY2023 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2335609 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4088294 | usd |
CY2023 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2293767 | usd |
CY2022 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
5572721 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5677485 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8018255 | usd |
CY2023 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
27191 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
4421995 | usd |
CY2022 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
26528630 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
10334052 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
48629895 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6899049 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-43083228 | usd |
CY2023 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-1130343 | usd |
CY2022 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-853566 | usd |
CY2023 | gryp |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
-370457 | usd |
CY2022 | gryp |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
-2884273 | usd |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-63178 | usd |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-202820 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-221101 | usd |
CY2023 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1703620 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-3895762 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-8602669 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-46978990 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-701119 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-8602669 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-46277871 | usd |
CY2023 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-2975500 | usd |
CY2022 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-32779739 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11578169 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-79057610 | usd |
CY2022 | us-gaap |
Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
|
955500 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-11578169 | usd |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-80013110 | usd |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
371020 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
146393 | shares |
CY2023 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-23.19 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-322.65 | |
CY2023 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-8.02 | |
CY2022 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-223.92 | |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-31.21 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-546.56 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11578169 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-79057610 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-72100 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
40577 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-48000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
245000 | usd |
CY2023 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-11698269 | usd |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-78772033 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
59949683 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
3925500 | usd |
CY2022 | us-gaap |
Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
|
-9926 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
940000 | usd |
CY2022 | us-gaap |
Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
|
9178961 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
843693 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
1854565 | usd |
CY2022 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
955500 | usd |
CY2022 | gryp |
Stock Issued During Period Value Settlement Of Liabilities
StockIssuedDuringPeriodValueSettlementOfLiabilities
|
49529 | usd |
CY2022 | gryp |
Stock Issued During Period Value Restricted Stock Vesting
StockIssuedDuringPeriodValueRestrictedStockVesting
|
50000 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
40577 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
245000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-79057610 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4825528 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
3187101 | usd |
CY2023 | gryp |
Stock Issued During Period Value Common Shares Issued In A Private Placement Offering
StockIssuedDuringPeriodValueCommonSharesIssuedInAPrivatePlacementOffering
|
500000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
403501 | usd |
CY2023 | gryp |
Stock Issued During Period Settlement Of Convertible Notes For Series C Preferred Stock
StockIssuedDuringPeriodSettlementOfConvertibleNotesForSeriesCPreferredStock
|
3422000 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-72100 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
-48000 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11578169 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9011195 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11578169 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-79057610 | usd |
CY2023 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
212601 | usd |
CY2022 | us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
221101 | usd |
CY2023 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
56855 | usd |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
371364 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
403501 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
873929 | usd |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
918898 | usd |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7834712 | usd |
CY2023 | us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
39285 | usd |
CY2022 | us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
337350 | usd |
CY2022 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
597276 | usd |
CY2023 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
22506 | usd |
CY2022 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
14553 | usd |
CY2023 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
3065365 | usd |
CY2022 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
61778605 | usd |
CY2023 | gryp |
Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
|
-370457 | usd |
CY2022 | gryp |
Gains Losses On Convertible Notes
GainsLossesOnConvertibleNotes
|
-2884273 | usd |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-63178 | usd |
CY2022 | us-gaap |
Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
|
4016194 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-8295 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-197647 | usd |
CY2023 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-602216 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-257555 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-9700 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
870152 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-324166 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
675291 | usd |
CY2023 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-410100 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-2113249 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5888352 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10900729 | usd |
CY2022 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
4345260 | usd |
CY2022 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
31884 | usd |
CY2022 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
-400000 | usd |
CY2023 | us-gaap |
Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
|
1237362 | usd |
CY2022 | us-gaap |
Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
|
5000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
1237362 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3972144 | usd |
CY2023 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
49 | usd |
CY2022 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
9926 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
9178960 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
1 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
500000 | usd |
CY2022 | us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
1854565 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
1650000 | usd |
CY2023 | gryp |
Principal Paymentsof Convertible Notes
PrincipalPaymentsofConvertibleNotes
|
4917356 | usd |
CY2022 | gryp |
Principal Paymentsof Convertible Notes
PrincipalPaymentsofConvertibleNotes
|
1432273 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
|
4294500 | usd |
CY2022 | us-gaap |
Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
|
5250000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2767405 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
8635827 | usd |
CY2023 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3601 | usd |
CY2022 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-22225 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-7414794 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6259271 | usd |
CY2022Q4 | gryp |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations
|
7877844 | usd |
CY2021Q4 | gryp |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations
|
12937554 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
305411 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1504972 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
8183255 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
14442526 | usd |
CY2023Q4 | gryp |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations
|
768461 | usd |
CY2022Q4 | gryp |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations
|
7877844 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
305411 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
768461 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
8183255 | usd |
CY2022 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
15684 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
787187 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
256440 | usd |
CY2022 | gryp |
Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
|
50000 | usd |
CY2023 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
3187101 | usd |
CY2022 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
3925500 | usd |
CY2023 | gryp |
Settlement Of Convertible Notes In Preferred Stock
SettlementOfConvertibleNotesInPreferredStock
|
3422000 | usd |
CY2022 | gryp |
Stock Based Compensation Capitalized As Software Development
StockBasedCompensationCapitalizedAsSoftwareDevelopment
|
19764 | usd |
CY2022 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
17974 | usd |
CY2023 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
285253 | usd |
CY2022 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
180647 | usd |
CY2022 | gryp |
Settlement Of Liabilities With Common Stock
SettlementOfLiabilitiesWithCommonStock
|
49529 | usd |
CY2022 | gryp |
Shares Returned In Connection With Acquisition
SharesReturnedInConnectionWithAcquisition
|
940000 | usd |
CY2023 | gryp |
Termination Of Contingent Consideration Obligation Due To Sale Of Discontinued Operations
TerminationOfContingentConsiderationObligationDueToSaleOfDiscontinuedOperations
|
2283806 | usd |
CY2022 | gryp |
Reduction To Accrued Expenses From An Acquisitionrelated Working Capital Settlement
ReductionToAccruedExpensesFromAnAcquisitionrelatedWorkingCapitalSettlement
|
160000 | usd |
CY2023 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – Description of Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gryphon Digital Mining, Inc. (“Gryphon”), which originally began operations as Ivy Crypto, Inc., was incorporated under the provisions and by the virtue of the provisions of the General Corporation Law of the State of Delaware on October 22, 2020, with its office located in Las Vegas, Nevada. Gryphon operates a digital asset (commonly referred to as cryptocurrency) mining operation using specialized computers equipped with application-specific integrated circuit (ASIC) chips (known as “miners”) to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) in exchange for cryptocurrency rewards (primarily Bitcoin). Gryphon became a publicly held entity in February 2024 upon the completion of a reverse merger transaction (the “Merger”) with Akerna Corp., herein referred to as we, us, our, the Company or Akerna. These consolidated financial statements and notes thereto, including disclosures for certain activities up to and including the effective date (the “Effective Date”) of the Merger, or February 9, 2024, are exclusively attributable to the operations of Akerna. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Akerna was formed upon completion of the mergers between MTech Acquisition Corp. (“MTech”) and MJ Freeway, LLC (“MJF”) on June 17, 2019 as contemplated by the Merger Agreement dated October 10, 2018, as amended (the “Formation Mergers”). Akerna provided software as a service (“SaaS”) solutions within the cannabis industry that enabled regulatory compliance and inventory management through several wholly-owned subsidiaries including MJF, Trellis Solutions, Inc. (“Trellis”), Ample Organics, Inc. (“Ample”), Last Call Analytics (“LCA”), solo sciences, inc. (“Solo”), Viridian Sciences, Inc. (“Viridian”), and The NAV People, Inc. d.b.a. 365 Cannabis (“365 Cannabis”). Our common stock, $0.0001 par value (“Common Stock”) was traded on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “KERN” through February 9, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the fourth quarter of 2022, we committed to a number of significant actions that collectively represented a strategic shift in our business strategy and a complete exit from the SaaS business serving the cannabis industry. The shift was effectuated in a two-part exit strategy whereby we (i) disposed of our component SaaS business units in advance of (ii) the Merger with Gryphon, an entity unaffiliated with the SaaS and cannabis industries (see below and Note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Prior to the aforementioned shift in strategy, we implemented a restructuring initiative (the “Restructuring”) in May 2022 whereby we reduced our headcount by 59 employees and incurred and paid $0.6 million of associated costs in an effort to minimize costs and streamline the organization. There were no remaining obligations under the Restructuring after December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, we disposed of 365 Cannabis, LCA and Ample (the “Disposal Group”) through a series of sale transactions. As a result of these transactions, the Disposal Group met the criteria to be considered “discontinued operations” as that term is defined in accounting principles generally accepted in the United States (“GAAP”). Accordingly, the assets and liabilities of these entities are classified and reflected on our consolidated balance sheet as of December 31, 2022 as attributable to “discontinued operations” and their results of operations are classified as “discontinued operations” in the consolidated statements of operations for the years ended December 31, 2023 and 2022, respectively. Certain financial disclosures including major components of the assets and liabilities and results of operations of the Disposal Group are provided in Note 15. We effectively abandoned our operations for Trellis, Solo and Viridian during the year ended December 31, 2023 after all contractual commitments were satisfied with the customers and vendors of those businesses. The results of operations of these business units are reflected in these consolidated financial statements for all periods presented as a component of continuing operations. We committed to the sale of MJF (the “Sale Transaction”) during 2023; however, the required stockholder approval and certain other consents required to complete the Sale Transaction were not obtained until January of 2024. Accordingly, the assets and liabilities and results of operations of MJF are reflected in these consolidated financial statements for all periods presented as a component of continuing operations. The Sale Transaction closed on February 9, 2024 (see Note 4).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 27, 2023, we entered into an agreement and plan of merger, as amended on April 28, 2023 and June 14, 2023 (the “Merger Agreement”) with Gryphon and Akerna Merger Co. (“Akerna Merger”). Required approval of the Merger Agreement by the stockholders of Akerna and Gryphon as well as approval by Nasdaq of the continued listing of Gryphon after the closing of the Merger was obtained in January 2024. On February 9, 2024, concurrent with the closing of the Sale Transaction, Akerna Merger merged with and into Gryphon, with Gryphon surviving the Merger as a wholly-owned subsidiary of Akerna. Following the closing of the Merger, the former Gryphon and Akerna stockholders immediately before the Merger owned approximately 92.5 percent and 7.5 percent, respectively, of the outstanding capital stock on a fully diluted basis which effectively resulted in a change in control of the Company. Upon completion of the Merger, Akerna changed its name to Gryphon and its common stock began trading on the Nasdaq under the symbol “GRYP.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional disclosures regarding the Merger and Sale Transaction and their impact on the results of operations for the year ended December 31, 2023 are more fully described in Note 4.</span></p> | |
CY2022Q2 | gryp |
Incurred Paid
IncurredPaid
|
600000 | usd |
CY2023 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – Basis of Presentation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements, which exclusively represent the operations of Akerna through December 31, 2023 and disclosures regarding certain activities up to and including the Effective Date, have been prepared in accordance with GAAP. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going Concern and Management</i>’<i>s Liquidity Plans</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standard Codification (“ASC”) 205-40, <i>Going Concern</i> (“ASC 205-40”), we assess going concern uncertainty in our consolidated financial statements to determine if we have sufficient cash, cash equivalents and working capital on hand and any available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued, which is defined as the “look-forward period” in ASC 205-40. As part of this assessment, based on conditions that are known and reasonably knowable to us, we will consider various scenarios, forecasts, projections, estimates and will make certain key assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail expenditures or programs, if necessary, among other factors. Based on this assessment, as necessary or applicable, we make certain assumptions regarding implementing curtailments or delays in the nature and timing of programs and expenditures to the extent we deem probable that such implementations can be achieved and we have the proper authority to execute them within the look-forward period in accordance with ASC 205-40.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on the basis that Akerna will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since our inception in 2019 we have incurred recurring losses from operations, used cash from operating activities and relied on capital raising activities to continue ongoing operations. Collectively, these factors raise substantial doubt regarding our ability to continue as a going concern for the twelve months from the date our consolidated financial statements were issued in the absence of a significant capital transaction. The accompanying consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should Akerna be unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In connection with the closing of the Sale Transaction and Merger, substantially all of the assets and liabilities of the legacy Akerna business were disposed of such that after February 8, 2024, our assets and liabilities and capital structure reflected those of Gryphon immediately after the closing of those transactions. Since Gryphon began revenue generation in September 2021, management has financed its operations through equity and debt financing and the sale of the digital assets earned through mining operations. Gryphon may incur additional losses from operations and negative cash outflows from operations in the foreseeable future. In the event Gryphon continues to incur losses, it may need to raise debt or equity financing to finance its operations until operations are cashflow positive. However, there can be no assurance that such financing will be available in sufficient amounts and on acceptable terms, when and if needed, or at all. The precise amount and timing of the funding needs cannot be determined accurately at this time and will depend on several factors, including the market price for the underlying commodity mined by the Company and its ability to procure the required mining equipment and operate profitably. The aforementioned factors indicate that management’s plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reclassifications</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts have been reclassified to conform to the current year presentation. In addition, and as described and disclosed in Notes 1 and 15, the assets and liabilities and results of operations of the Disposal Group have been reclassified as discontinued operations for all period presented.</span></p> | |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the consolidated financial statements and accompanying notes thereto. Our most significant estimates and assumptions are related to impairment assessments, loss contingencies and the valuation allowance associated with deferred tax assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates. </span></p> | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
100000 | usd |
CY2023Q1 | us-gaap |
Securities Purchased Under Agreements To Resell
SecuritiesPurchasedUnderAgreementsToResell
|
4000000 | usd |
CY2023Q2 | us-gaap |
Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
|
200000 | usd |
CY2023Q2 | gryp |
Purchase Price Value
PurchasePriceValue
|
5000000 | usd |
CY2023Q2 | gryp |
Purchase Price Value In Cash
PurchasePriceValueInCash
|
4000000 | usd |
CY2023 | gryp |
Cash Paid
CashPaid
|
1850000 | usd |
CY2023Q4 | us-gaap |
Cash
Cash
|
4000000 | usd |
CY2023Q4 | us-gaap |
Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
|
1650000 | usd |
CY2023Q1 | gryp |
Percent Of The Outstanding Shares Of Common Stock
PercentOfTheOutstandingSharesOfCommonStock
|
0.199 | pure |
CY2023Q1 | us-gaap |
Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
|
95 | |
CY2023Q4 | us-gaap |
Shares Issued
SharesIssued
|
1711 | shares |
CY2023Q4 | us-gaap |
Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
|
100 | shares |
CY2023 | us-gaap |
Revenues
Revenues
|
6836444 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
10458170 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
147855 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
429949 | usd |
CY2022Q4 | gryp |
Percentage Of Account Receivable From Customers
PercentageOfAccountReceivableFromCustomers
|
0.51 | pure |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
80759 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
331262 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
305517 | usd |
CY2023 | gryp |
Accounts Receivable Allowancefor Credit Loss Bad Debt Expense
AccountsReceivableAllowanceforCreditLossBadDebtExpense
|
63358 | usd |
CY2022 | gryp |
Accounts Receivable Allowancefor Credit Loss Bad Debt Expense
AccountsReceivableAllowanceforCreditLossBadDebtExpense
|
415009 | usd |
CY2023 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
377148 | usd |
CY2022 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
389264 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
17472 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
331262 | usd |
CY2023Q4 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
2500000 | usd |
CY2023 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
6800000 | usd |
CY2022 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
10500000 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
500000 | usd |
CY2021Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
1200000 | usd |
CY2023 | gryp |
Customer Relationship Period
CustomerRelationshipPeriod
|
P1Y | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
154137 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
59070 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
105257 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
21689 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
48880 | usd |
CY2023 | us-gaap |
Depreciation
Depreciation
|
27883 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
44841 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
28700000 | usd |
CY2022Q4 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
6100000 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Current
IntangibleAssetsCurrent
|
3900000 | usd |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
18700000 | usd |
CY2022 | us-gaap |
Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
|
2200000 | usd |
CY2022Q4 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
4400000 | usd |
CY2022Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
700000 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3700000 | usd |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
26500000 | usd |
CY2022 | us-gaap |
Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
|
4600000 | usd |
CY2022Q4 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
3200000 | usd |
CY2022 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
18700000 | usd |
CY2023Q4 | gryp |
Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
|
27518 | usd |
CY2022Q4 | gryp |
Prepaid Expenses Software And Technology
PrepaidExpensesSoftwareAndTechnology
|
309466 | usd |
CY2023Q4 | gryp |
Prepaid Professional Services Dues And Subscriptions
PrepaidProfessionalServicesDuesAndSubscriptions
|
4723 | usd |
CY2022Q4 | gryp |
Prepaid Professional Services Dues And Subscriptions
PrepaidProfessionalServicesDuesAndSubscriptions
|
18268 | usd |
CY2022Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
168935 | usd |
CY2022Q4 | us-gaap |
Other Deferred Costs Net
OtherDeferredCostsNet
|
36465 | usd |
CY2023Q4 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
370326 | usd |
CY2022Q4 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
534925 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
17515 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
53704 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
420082 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1121763 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2165342 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1417835 | usd |
CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1041699 | usd |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
143749 | usd |
CY2023Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
107923 | usd |
CY2022Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
63983 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
397754 | usd |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
334514 | usd |
CY2023Q4 | gryp |
Accrued Contractors
AccruedContractors
|
160739 | usd |
CY2022Q4 | gryp |
Accrued Contractors
AccruedContractors
|
521145 | usd |
CY2023Q4 | us-gaap |
Settlement Liabilities Current
SettlementLiabilitiesCurrent
|
248031 | usd |
CY2022Q4 | us-gaap |
Settlement Liabilities Current
SettlementLiabilitiesCurrent
|
934396 | usd |
CY2023Q4 | us-gaap |
Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
|
699142 | usd |
CY2022Q4 | us-gaap |
Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
|
597873 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
9688 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4820630 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4023183 | usd |
CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
5149000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
14607000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
5149000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
13200000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
1407000 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
4900000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
3500000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
14600000 | usd |
CY2023Q2 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
650000 | usd |
CY2023Q4 | gryp |
Aggregate Maturities
AggregateMaturities
|
3136271 | usd |
CY2023Q4 | gryp |
Maturities Due For The Amended
MaturitiesDueForTheAmended
|
1650000 | usd |
CY2023Q4 | gryp |
Debt Original Issue Discount
DebtOriginalIssueDiscount
|
2000000 | usd |
CY2023Q4 | gryp |
Cumulative Unrealized Change In Fair Value
CumulativeUnrealizedChangeInFairValue
|
2362729 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
5149000 | usd |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
-50000 | usd |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2826 | usd |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-47174 | usd |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-653945 | usd |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-653945 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-701119 | usd |
CY2023 | gryp |
Tax Reconciliation Not Required
TaxReconciliationNotRequired
|
-2406564 | usd |
CY2022 | gryp |
Tax Reconciliation Not Required
TaxReconciliationNotRequired
|
-16749778 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-252836 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-853392 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-76018 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-11543 | usd |
CY2023 | gryp |
Income Tax Reconciliation Transaction Costs
IncomeTaxReconciliationTransactionCosts
|
167137 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
207525 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
472270 | usd |
CY2023 | gryp |
Income Tax Reconciliation Goodwill Impairment
IncomeTaxReconciliationGoodwillImpairment
|
358744 | usd |
CY2022 | gryp |
Income Tax Reconciliation Goodwill Impairment
IncomeTaxReconciliationGoodwillImpairment
|
9172756 | usd |
CY2023 | gryp |
Income Tax Reconciliation Change In Rate
IncomeTaxReconciliationChangeInRate
|
-51003 | usd |
CY2022 | gryp |
Income Tax Reconciliation Change In Rate
IncomeTaxReconciliationChangeInRate
|
-992 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-3591436 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
7501917 | usd |
CY2023 | gryp |
Income Tax Reconciliation Provision Return Adjustment
IncomeTaxReconciliationProvisionReturnAdjustment
|
486727 | usd |
CY2022 | gryp |
Income Tax Reconciliation Provision Return Adjustment
IncomeTaxReconciliationProvisionReturnAdjustment
|
62788 | usd |
CY2023 | gryp |
Income Tax Reconciliation Deferred Trueups
IncomeTaxReconciliationDeferredTrueups
|
5157724 | usd |
CY2022 | gryp |
Income Tax Reconciliation Deferred Trueups
IncomeTaxReconciliationDeferredTrueups
|
-247839 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
-47306 | usd |
CY2022 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-701119 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
63091 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
136154 | usd |
CY2022Q4 | gryp |
Deferred Tax Assets Debt Issuance Costs
DeferredTaxAssetsDebtIssuanceCosts
|
39381 | usd |
CY2022Q4 | gryp |
Deferred Tax Asset Revenue Recognition
DeferredTaxAssetRevenueRecognition
|
64662 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
|
49575 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
|
178549 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
171268 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
774936 | usd |
CY2023Q4 | gryp |
Deferred Tax Asset Section174 Capitalization
DeferredTaxAssetSection174Capitalization
|
1219926 | usd |
CY2022Q4 | gryp |
Deferred Tax Asset Section174 Capitalization
DeferredTaxAssetSection174Capitalization
|
1121311 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
14226635 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
13860338 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
56739 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
4641293 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
4718 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
280430 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
15791952 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
21097054 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
1713666 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
1713666 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
15791952 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
19383388 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-3600000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
7500000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
59500000 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.80 | pure |
CY2023Q4 | us-gaap |
Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
|
100000 | usd |
CY2023Q4 | gryp |
Percentage Of Commitment To Compensate Financial Advisor
PercentageOfCommitmentToCompensateFinancialAdvisor
|
0.03 | pure |
CY2023Q4 | gryp |
Accrued Advisor
AccruedAdvisor
|
650000 | usd |
CY2023Q2 | gryp |
Termination Fee And Related Expenses
TerminationFeeAndRelatedExpenses
|
200000 | usd |
CY2022Q4 | gryp |
Original Issue Discount To The Stated Value Percentage
OriginalIssueDiscountToTheStatedValuePercentage
|
0.05 | pure |
CY2022Q4 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10 | |
CY2022Q4 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4750000 | usd |
CY2022Q4 | us-gaap |
Professional Fees
ProfessionalFees
|
400000 | usd |
CY2022Q4 | us-gaap |
Legal Fees
LegalFees
|
100000 | usd |
CY2022Q4 | us-gaap |
Escrow Deposit
EscrowDeposit
|
500000 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
|
5 | |
gryp |
Convertible Redeemable Preferred Stock Percent
ConvertibleRedeemablePreferredStockPercent
|
1.05 | pure | |
CY2022Q4 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.5 | |
CY2022Q4 | us-gaap |
Escrow Deposit
EscrowDeposit
|
5250000 | usd |
CY2023Q4 | us-gaap |
Excess Stock Shares Issued
ExcessStockSharesIssued
|
3422 | shares |
CY2023Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
3422000 | usd |
CY2023Q4 | gryp |
Exchangeable Shares Outstanding
ExchangeableSharesOutstanding
|
248484 | shares |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
92 | |
CY2022Q3 | us-gaap |
Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
|
9200000 | usd |
CY2022Q3 | us-gaap |
Restricted Cash And Investments
RestrictedCashAndInvestments
|
7000000 | usd |
CY2023Q4 | gryp |
Warrants Outstanding
WarrantsOutstanding
|
45652174 | shares |
CY2023 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
114130 | shares |
CY2023Q4 | gryp |
Common Warrants Shares
CommonWarrantsShares
|
43478261 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
9200000 | usd |
CY2023 | us-gaap |
Class Of Warrant Or Right Expense Or Revenue Recognized
ClassOfWarrantOrRightExpenseOrRevenueRecognized
|
In connection with MTech’s initial public offering, MTech sold units consisting of one share of MTech’s common stock and one warrant of MTech (“MTech Public Warrant”). Each MTech Public Warrant entitled the holder to purchase one share of MTech’s common stock. Concurrently with MTech’s initial public offering, MTech sold additional units on a private offering basis. Each of these units consisted of one share of MTech’s common stock and one warrant of MTech (“MTech Private Warrant”). | |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
51465978 | shares |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
51465978 | shares |
CY2019Q2 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
1040038 | shares |
CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
525000 | shares |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
2934962 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
11250 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
8714 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
1790 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
2188 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
707 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
270.8 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
1188 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
1081.2 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
739 | shares |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
2248.2 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
570 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1793.2 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
276 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
2045.8 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
113 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
1372.4 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
181 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
1801 | |
CY2022 | us-gaap |
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
|
100000 | usd |
CY2023Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
300000 | usd |
CY2023 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P0Y10M13D | |
CY2023Q4 | us-gaap |
Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
|
6300000 | usd |
CY2022Q3 | us-gaap |
Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
|
3000000 | usd |
CY2022Q4 | us-gaap |
Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
|
2300000 | usd |
CY2021Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
17305000 | usd |
CY2022 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
5337273 | usd |
CY2022 | us-gaap |
Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
|
2884273 | usd |
CY2022 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-245000 | usd |
CY2022Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
14607000 | usd |
CY2023 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
11526457 | usd |
CY2023 | us-gaap |
Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
|
370457 | usd |
CY2023 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
48000 | usd |
CY2023Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
3499000 | usd |
CY2023 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
162483 | shares |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
284296 | shares |
CY2023Q1 | gryp |
Termination Of Contingent Consideration Obligation Due To Sale Of Discontinued Operations
TerminationOfContingentConsiderationObligationDueToSaleOfDiscontinuedOperations
|
500000 | usd |
CY2022Q4 | us-gaap |
Purchase Obligation
PurchaseObligation
|
2300000 | usd |
CY2022Q4 | gryp |
Orginal Estimate Amount
OrginalEstimateAmount
|
4000000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
100000 | usd |
CY2023 | us-gaap |
Other Adjustments To Income Discontinued Operations
OtherAdjustmentsToIncomeDiscontinuedOperations
|
200000 | usd |
CY2023 | us-gaap |
Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
|
638000 | usd |
CY2023 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
2412534 | usd |
CY2022 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
12640170 | usd |
CY2023 | us-gaap |
Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
|
575246 | usd |
CY2022 | us-gaap |
Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
|
2919208 | usd |
CY2023 | us-gaap |
Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
|
1837288 | usd |
CY2022 | us-gaap |
Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
|
9720962 | usd |
CY2023 | gryp |
Discontinued Operation Product And Development Expense
DiscontinuedOperationProductAndDevelopmentExpense
|
527301 | usd |
CY2022 | gryp |
Discontinued Operation Product And Development Expense
DiscontinuedOperationProductAndDevelopmentExpense
|
2409740 | usd |
CY2023 | gryp |
Discontinued Operation Selling And Marketing Expense
DiscontinuedOperationSellingAndMarketingExpense
|
421049 | usd |
CY2022 | gryp |
Discontinued Operation Selling And Marketing Expense
DiscontinuedOperationSellingAndMarketingExpense
|
4646997 | usd |
CY2023 | gryp |
Disposal Group Including Discontinued Operation General And Administrative
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrative
|
118133 | usd |
CY2022 | gryp |
Disposal Group Including Discontinued Operation General And Administrative
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrative
|
798837 | usd |
CY2023 | us-gaap |
Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
|
891708 | usd |
CY2022 | us-gaap |
Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
|
3412717 | usd |
CY2023 | gryp |
Discontinued Operation Impairment Of Long Lived Assets Held For Use
DiscontinuedOperationImpairmentOfLongLivedAssetsHeldForUse
|
3065365 | usd |
CY2022 | gryp |
Discontinued Operation Impairment Of Long Lived Assets Held For Use
DiscontinuedOperationImpairmentOfLongLivedAssetsHeldForUse
|
35249975 | usd |
CY2022 | gryp |
Disposalof Group Changes In Fair Value Of Contingent Consideration
DisposalofGroupChangesInFairValueOfContingentConsideration
|
-4016194 | usd |
CY2023 | us-gaap |
Disposal Group Including Discontinued Operation Other Expense
DisposalGroupIncludingDiscontinuedOperationOtherExpense
|
1833 | usd |
CY2022 | us-gaap |
Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
|
746 | usd |
CY2023 | gryp |
Loss From Discontinued Operations Before Income Taxes
LossFromDiscontinuedOperationsBeforeIncomeTaxes
|
-3188101 | usd |
CY2022 | gryp |
Loss From Discontinued Operations Before Income Taxes
LossFromDiscontinuedOperationsBeforeIncomeTaxes
|
-32781856 | usd |
CY2022 | us-gaap |
Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal
DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
|
2117 | usd |
CY2023 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
|
-3188101 | usd |
CY2022 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
|
-32779739 | usd |
CY2023 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
212601 | usd |
CY2023 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-2975500 | usd |
CY2022 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-32779739 | usd |
CY2023 | gryp |
Disposal Group Including Discontinued Operation In Impairments Of Longlived Assets
DisposalGroupIncludingDiscontinuedOperationInImpairmentsOfLonglivedAssets
|
3100000 | usd |
CY2023Q4 | us-gaap |
Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
|
1700000 | usd |
CY2022 | gryp |
Disposal Group Including Discontinued Operation In Impairments Of Longlived Assets
DisposalGroupIncludingDiscontinuedOperationInImpairmentsOfLonglivedAssets
|
35200000 | usd |
CY2022Q4 | us-gaap |
Disposal Group Including Discontinued Operation Goodwill Current
DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent
|
25000000 | usd |
CY2022Q4 | us-gaap |
Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
|
9900000 | usd |
CY2022 | gryp |
Disposal Group Including Discontinued Operation In Capitalized Software
DisposalGroupIncludingDiscontinuedOperationInCapitalizedSoftware
|
300000 | usd |
CY2022 | gryp |
Disposal Group Including Discontinued Operation Accounts Receivable Credit Loss Expense Reversal
DisposalGroupIncludingDiscontinuedOperationAccountsReceivableCreditLossExpenseReversal
|
1700000 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
200000 | usd |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
688 | |
CY2023Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
usd | |
CY2023Q4 | us-gaap |
Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
|
usd | |
CY2023Q4 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
usd | |
CY2023Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
usd | |
CY2023Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
usd | |
CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
usd | |
CY2023Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
usd | |
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
usd | |
CY2023 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
usd | |
CY2023 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
|
usd | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-322.65 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-23.19 | |
CY2022 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-223.92 | |
CY2023 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-8.02 | |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
usd | |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
usd | |
CY2022 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
usd | |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
|
usd | |
CY2023 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
usd | |
CY2023 | gryp |
Stock Issued During Period Value Restricted Stock Vesting
StockIssuedDuringPeriodValueRestrictedStockVesting
|
usd | |
CY2022 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
usd | |
CY2023 | us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
usd | |
CY2023 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
usd | |
CY2023 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | |
CY2023 | us-gaap |
Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
|
usd | |
CY2023 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
usd | |
CY2023 | us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
usd | |
CY2023 | us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
usd | |
CY2023 | us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
usd | |
CY2023 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
usd | |
CY2022 | us-gaap |
Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
|
usd | |
CY2023 | us-gaap |
Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
|
usd | |
CY2023 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
usd | |
CY2023 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
usd | |
CY2022 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
usd | |
CY2023 | us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
usd | |
CY2022 | us-gaap |
Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
|
usd | |
CY2023 | us-gaap |
Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
|
usd | |
CY2023 | us-gaap |
Payments For Repurchase Of Redeemable Convertible Preferred Stock
PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
|
usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
usd | |
CY2023 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2023 | gryp |
Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
|
usd | |
CY2022 | gryp |
Settlement Of Convertible Notes In Preferred Stock
SettlementOfConvertibleNotesInPreferredStock
|
usd | |
CY2023 | gryp |
Stock Based Compensation Capitalized As Software Development
StockBasedCompensationCapitalizedAsSoftwareDevelopment
|
usd | |
CY2023 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
usd | |
CY2023 | gryp |
Settlement Of Liabilities With Common Stock
SettlementOfLiabilitiesWithCommonStock
|
usd | |
CY2023 | gryp |
Shares Returned In Connection With Acquisition
SharesReturnedInConnectionWithAcquisition
|
usd | |
CY2022 | gryp |
Termination Of Contingent Consideration Obligation Due To Sale Of Discontinued Operations
TerminationOfContingentConsiderationObligationDueToSaleOfDiscontinuedOperations
|
usd | |
CY2023 | gryp |
Reduction To Accrued Expenses From An Acquisitionrelated Working Capital Settlement
ReductionToAccruedExpensesFromAnAcquisitionrelatedWorkingCapitalSettlement
|
usd | |
CY2023Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
usd | |
CY2023Q4 | us-gaap |
Other Deferred Costs Net
OtherDeferredCostsNet
|
usd | |
CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
usd | |
CY2023 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | gryp |
Income Tax Reconciliation Transaction Costs
IncomeTaxReconciliationTransactionCosts
|
usd | |
CY2023 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
usd | |
CY2023 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
usd | |
CY2023Q4 | gryp |
Deferred Tax Assets Debt Issuance Costs
DeferredTaxAssetsDebtIssuanceCosts
|
usd | |
CY2023Q4 | gryp |
Deferred Tax Asset Revenue Recognition
DeferredTaxAssetRevenueRecognition
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
|
usd | |
CY2023Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2023 | gryp |
Warrants Issued In Periods Number Of Shares
WarrantsIssuedInPeriodsNumberOfShares
|
shares | |
CY2023 | gryp |
Warrants Forfeited In Period Weighted Average Grant Date Fair Value
WarrantsForfeitedInPeriodWeightedAverageGrantDateFairValue
|
||
CY2023 | gryp |
Class Of Warrant Or Righst From Which Warrants Or Rights Expired
ClassOfWarrantOrRighstFromWhichWarrantsOrRightsExpired
|
||
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
shares | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
||
CY2023 | gryp |
Disposalof Group Changes In Fair Value Of Contingent Consideration
DisposalofGroupChangesInFairValueOfContingentConsideration
|
usd | |
CY2022 | us-gaap |
Disposal Group Including Discontinued Operation Other Expense
DisposalGroupIncludingDiscontinuedOperationOtherExpense
|
usd | |
CY2023 | us-gaap |
Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
|
usd | |
CY2023 | us-gaap |
Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal
DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal
|
usd | |
CY2022 | us-gaap |
Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
|
usd | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001755953 |